Evaluation of safety and efficacy of Pramehakulantaka Rasa in the management of Madhumeha (Diabetes Mellitus TypeII)
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2019/05/019339
- Lead Sponsor
- ational Institute of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 64
1.Patients ready to give concern for the trial & willing to participate in the study for 3 months.
2.Patients between the age group of 31-70 years in either sex.
3.Newly diagnosed & confirmed cases of Mahdumeha (Type II Diabetes Mellitus) not talking allopathic drug or Insulin Therapy.
4.Patients with Fasting Blood Sugar (FBS) in the range of 126mg/dl â?? 250mg/dl or Post Prandial Blood Sugar (PPBS) in the range of 200mg/dl â?? 300 mg/dl and Glycosylated Haemoglobin (HbA1c) 6.5% - 9.0%.
5.Presence of Cardinal symptoms of Diabetes Mellitus eg. (3P- polyuria, polydipsia, polyphagia).
1.Patients below 31years of age & above 70 years of age.
2.Patients having Type I DM.
3.F.B.S. > 250 mg/dl and P.P.B.S. > 300 mg/dl.
4.Patients of Type II DM who are on insulin therapy and Drug induced DM.
5.Patients on allopathic anti-diabetic drug.
6.DM with complications and Madhumeha with ashadhya upadrava.
7.Patients having any serious illness like cardiovascular diseases, renal diseases, hepatic diseases, malignancy, any other endocrinopathies etc.
8.Pregnant and lactating mother.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in the clinical symptoms of Mahdumeha (Type II Diabetes Mellitus)Timepoint: 90 days
- Secondary Outcome Measures
Name Time Method Changes in the objective parameters- F.B.S., P.P.B.S. & HbA1c. <br/ ><br>Timepoint: 90 Days